Nifekalant unmasked residual gap of superior vena cava isolation by suppressing immediate recurrence of intra-superior vena cava fibrillation

J Arrhythm. 2022 Oct 3;38(6):1094-1098. doi: 10.1002/joa3.12788. eCollection 2022 Dec.

Abstract

Nifekalant successfully suppressed intra-superior vena cava fibrillation, which complicated the evaluation of the gap of superior vena cava isolation.

Keywords: Nifekalant; atrial fibrillation; immediate recurrence of atrial fibrillation; superior vena cava isolation.